Ocrelizumab, Primary Progressive Multiple Sclerosis (872)

Warning

exp date isn't null, but text field is

Resources

Use the button below to access this resource item.

Access this resource

Tags

All Primary Care
Acute / All Inpatient

Last reviewed: 18 March 2020

Next review: 31 July 2023

Author(s): Lesley Murray, Pushkar Shah

Author Email(s): [email protected], [email protected]

Approved By: Medicines Utilsation Subcommittee of ADTC

Document Id: 872